Literature DB >> 24359990

Hereditary kidney cancer syndromes.

Naomi B Haas1, Katherine L Nathanson2.   

Abstract

Inherited susceptibility to kidney cancer is a fascinating and complex topic. Our knowledge about types of genetic syndromes associated with an increased risk of disease is continually expanding. Currently, there are 10 syndromes associated with an increased risk of all types of kidney cancer, which are reviewed herein. Clear cell kidney cancer is associated with von Hippel Lindau disease, chromosome 3 translocations, PTEN hamartomatous syndrome, and mutations in the BAP1 gene as well as several of the genes encoding the proteins comprising the succinate dehydrogenase complex (SDHB/C/D). Type 1 papillary kidney cancers arise in conjunction with germline mutations in MET and type 2 as part of hereditary leiomyomatosis and kidney cell cancer (fumarate hydratase [FH] mutations). Chromophone and oncocytic kidney cancers are predominantly associated with Birt-Hogg-Dubé syndrome. Patients with Tuberous Sclerosis Complex (TSC) commonly have angiomyolipomas and rarely their malignant counterpart epithelioid angiomyolipomas. The targeted therapeutic options for the kidney cancer associated with these diseases are just starting to expand and are an area of active clinical research.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Birt-Hogg-Dube disease; Genetic disease; Genetic susceptibility; Kidney cancer; von Hippel Lindau disease

Mesh:

Substances:

Year:  2014        PMID: 24359990      PMCID: PMC3872053          DOI: 10.1053/j.ackd.2013.10.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  125 in total

1.  Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations.

Authors:  M Maradin; K Fumić; H Hansikova; M Tesarova; L Wenchich; S Dorner; V Sarnavka; J Zeman; I Barić
Journal:  J Inherit Metab Dis       Date:  2006-08-05       Impact factor: 4.982

Review 2.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

3.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

4.  Genotype-phenotype correlations in von Hippel-Lindau disease.

Authors:  Kai Ren Ong; Emma R Woodward; Pip Killick; Caron Lim; Fiona Macdonald; Eamonn R Maher
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

5.  Multiple cutaneous and uterine leiomyomas associated with gastric GIST.

Authors:  Manisha Lamba; Shailendra Verma; Robert Prokopetz; Tadeusz A Pierscianowski; Maha Jabi; Terence Moyana
Journal:  J Cutan Med Surg       Date:  2005-12       Impact factor: 2.092

Review 6.  Cancer phenomics: RET and PTEN as illustrative models.

Authors:  Kevin M Zbuk; Charis Eng
Journal:  Nat Rev Cancer       Date:  2006-12-14       Impact factor: 60.716

7.  Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations.

Authors:  Piotr Kozlowski; Penelope Roberts; Sandra Dabora; David Franz; John Bissler; Hope Northrup; Kit Sing Au; Ross Lazarus; Dorota Domanska-Pakiela; Katarzyna Kotulska; Sergiusz Jozwiak; David J Kwiatkowski
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

8.  The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.

Authors:  Maria J Merino; Carlos Torres-Cabala; Peter Pinto; William Marston Linehan
Journal:  Am J Surg Pathol       Date:  2007-10       Impact factor: 6.394

9.  Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.

Authors:  Lianjie Li; Liang Zhang; Xiaoping Zhang; Qin Yan; Yoji Andrew Minamishima; Aria F Olumi; Mao Mao; Steven Bartz; William G Kaelin
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

10.  Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.

Authors:  Robert L Grubb; Michael E Franks; Jorge Toro; Lindsay Middelton; Lynda Choyke; Sarah Fowler; Carlos Torres-Cabala; Gladys M Glenn; Peter Choyke; Maria J Merino; Berton Zbar; Peter A Pinto; Ramaprasad Srinivasan; Jonathan A Coleman; W Marston Linehan
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  38 in total

1.  Outcomes of synchronous and metachronous bilateral small renal masses (< 4 cm): a population-based cohort study.

Authors:  Nissar Ahmed Sheikh; Mohammed Hassan Khan; Sanjay Pillai; Stephen Lang; Ghulam Nabi
Journal:  Int Urol Nephrol       Date:  2018-02-10       Impact factor: 2.370

2.  A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC).

Authors:  Priya T Bhola; Cathy Gilpin; Amanda Smith; Gail E Graham
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  International cancer seminars: a focus on kidney cancer.

Authors:  G Scelo; J N Hofmann; R E Banks; P Bigot; R S Bhatt; G Cancel-Tassin; S K Chew; C J Creighton; O Cussenot; I J Davis; B Escudier; T M Frayling; C Häggström; M A T Hildebrandt; I Holcatova; M Johansson; W M Linehan; D F McDermott; K L Nathanson; S Ogawa; E J Perlman; M P Purdue; P Stattin; C Swanton; N S Vasudev; X Wu; A Znaor; P Brennan; S J Chanock
Journal:  Ann Oncol       Date:  2016-04-29       Impact factor: 32.976

Review 4.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

5.  Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.

Authors:  Junlong Wu; Hongkai Wang; Christopher J Ricketts; Youfeng Yang; Maria J Merino; Hailiang Zhang; Guohai Shi; Hualei Gan; W Marston Linehan; Yao Zhu; Dingwei Ye
Journal:  Cancer       Date:  2018-12-12       Impact factor: 6.860

6.  The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.

Authors:  Tongzhang Zheng; Cairong Zhu; Bryan A Bassig; Simin Liu; Stephen Buka; Xichi Zhang; Ashley Truong; Junhi Oh; John Fulton; Min Dai; Ni Li; Kunchong Shi; Zhengmin Qian; Peter Boyle
Journal:  Int J Epidemiol       Date:  2019-12-01       Impact factor: 7.196

Review 7.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

Review 8.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09

Review 9.  The Role of DNA Methylation in Renal Cell Carcinoma.

Authors:  Brittany N Lasseigne; James D Brooks
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 10.  Epidemiology and Risk Factors for Kidney Cancer.

Authors:  Ghislaine Scelo; Tricia L Larose
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.